Skin allograft in the treatment of toxic epidermal necrolysis (TEN)

被引：25

作者：

Pianigiani, E ^{[1
]}

Ierardi, F ^{[1
]}

Taddeucci, P ^{[1
]}

Perotti, R ^{[1
]}

Biagioli, M ^{[1
]}

Di Simplicio, FC ^{[1
]}

Andreassi, A ^{[1
]}

Fimiani, M ^{[1
]}

机构：

[1] Policlin Le Scotte, Dept Dermatol & Skin Bank, I-53100 Siena, Italy

来源：

DERMATOLOGIC SURGERY | 2002年 / 28卷 / 12期

关键词：

D O I：

10.1046/j.1524-4725.2002.02119.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

BACKGROUND. TEN is a severe form of exfoliative dermatitis. Its course is acute and its outcome fatal in 40% of cases. Wound cover to prevent fluid/protein loss and infections and to control pain, is the first step, as for burns. Skin allograft can be successfully used for this purpose. OBJECTIVE. We report two cases of TEN with de-epithelialization of 50 and 70% of the total body surface area. The patients were given support therapy and treated with human glycerol-preserved skin allografts for wound cover. METHODS. Patients were grafted with glycerol-preserved donor skin, obtained from a skin bank. RESULTS. Re-epithelization of treated areas was complete in 8 days; pain relief was obtained soon after the graft. CONCLUSIONS. Glycerol-preserved skin allograft is an effective treatment in extensive skin loss, for its barrier and analgesic effect. Quality standards of this product ensure safety and simplicity of use at limited cost.

引用

页码：1173 / 1176

页数：4

共 27 条

[1]

BERNAL FJG, 1998, ANN BURNS FIRE DISAS, V11, P217

[2] TOXIC EPIDERMAL NECROLYSIS - A REVIEW AND REPORT OF THE SUCCESSFUL USE OF BIOBRANE FOR EARLY WOUND COVERAGE [J].

BRADLEY, T ;

BROWN, RE ;

KUCAN, JO ;

SMOOT, EC ;

HUSSMANN, J .

ANNALS OF PLASTIC SURGERY, 1995, 35 (02) :124-132

[3] Ethics of xenotransplantation: Animal issues, consent, and likely transformation of transplant ethics [J].

Daar, AS .

WORLD JOURNAL OF SURGERY, 1997, 21 (09) :975-982

[4] Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis [J].

Egan, CA ;

Grant, WJ ;

Morris, SE ;

Saffle, JR ;

Zone, JJ .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (03) :458-461

[5] IMPROVED BURN CENTER SURVIVAL OF PATIENTS WITH TOXIC EPIDERMAL NECROLYSIS MANAGED WITHOUT CORTICOSTEROIDS [J].

HALEBIAN, PH ;

CORDER, VJ ;

MADDEN, MR ;

FINKLESTEIN, JL ;

SHIRES, GT .

ANNALS OF SURGERY, 1986, 204 (05) :503-512

[6]

HEIMBACH DM, 1987, JAMA-J AM MED ASSOC, V257, P2171

[7] EFFICACY OF CYCLOPHOSPHAMIDE IN TOXIC EPIDERMAL NECROLYSIS - CLINICAL AND PATHOPHYSIOLOGIC ASPECTS [J].

HENG, MCY ;

ALLEN, SG .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (05) :778-786

[8] TOXIC EPIDERMAL NECROLYSIS TREATED WITH CYCLOSPORINE [J].

HEWITT, J ;

ORMEROD, AD .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 (04) :264-265

[9] Toxic epidermal necrolysis (TEN) in elderly patients [J].

Honari, S ;

Gibran, NS ;

Heimbach, DM ;

Gibbons, J ;

Cain, V ;

Engrav, LH .

JOURNAL OF BURN CARE & REHABILITATION, 2001, 22 (02) :132-135

[10] Quality issues in skin banking: A review [J].

Kearney, JN .

BURNS, 1998, 24 (04) :299-305

← 1 2 3 →